Fund Holdings — Aquilo Capital Management, LLC

Total Portfolio Value
$0
Total Bought
$0
Total Sold
$37.08M
Net Transaction
-$37.08M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
No Securities00000—0
ZYMEWORKS INC(ZYME)84,4820-84,4821,0060—-1,006
REPARE THERAPEUTICS INC1,293,7150-1,293,7151,2750—-1,275
IMMATICS N.V(IMTX)304,9020-304,9021,3750—-1,375
BICYCLE THERAPEUTICS PLC171,6950-171,6951,4580—-1,458
ADICET BIO INC2,456,1940-2,456,1941,8540—-1,854
REGENXBIO INC(RGNX)271,3020-271,3021,9400—-1,940
ARVINAS INC(ARVN)360,7660-360,7662,5330—-2,533
PRECISION BIOSCIENCES INC(DTIL)726,1490-726,1493,4640—-3,464
KYMERA THERAPEUTICS INC(KYMR)138,5210-138,5213,7910—-3,791
PROTAGONIST THERAPEUTICS INC81,6920-81,6923,9510—-3,951
ARROWHEAD PHARMACEUTICALS IN(ARWR)550,1300-550,1307,0090—-7,009
BLUEPRINT MEDICINES CORP83,9260-83,9267,4280—-7,428
Page 1 of 1
Aquilo Capital Management, LLC — 13F Holdings — Q2 2025 | TickerTrail